Minimally Invasive Treatment Offered for Fibroid Tumors Nov 20, 2009
Dr. Samuel I. Wahl, an interventional radiologist with Pinehurst Radiology Associates, performs a procedure called uterine fibroid embolization (UFE) in which tiny beads are injected into arteries that supply blood to the fibroids ... "About 90 percent of women who undergo uterine fibroid embolization because of heavy bleeding experience total relief." ... Anyone wanting more information on the uterine fibroid embolization procedure performed by Wahl can call (800) 213-3284. (The Pilot Newspaper)
New hope for osteoporosis sufferers (6) Nov 9, 2009
It is primarily used to improve blood flow and may improve endometriosis, PMS, hemorrhoids and uterine fibroid tumors. The final main ingredient is strontium carbonate. (Park Hills Daily Journal, MO)
Repros settles with major creditors Oct 31, 2009
The clinical trial for Proellex, a drug for the treatment of uterine fibroids, was in August for safety reasons. Under the agreement, The Woodlands-based Repros will repay 10 of its creditors nearly $9 million in the form of about $3 million in cash and $6 million in unregistered stock priced at $1. (Houston Business Journal, TX)
Repros amends Proellex license Oct 30, 2009
In August, The Woodlands biopharmaceutical company put the experimental drug for uterine fibroids for safety reasons. The hold affected a variety of benchmark milestones used by the NIH to enforce its license. (Houston Business Journal, TX)
Glancy Binkow & Goldberg LLP, Representing Shareholders of Repros Therapeutics Inc., Announces There are 11 Days Remaining to Move for Appointment as Lead Plaintiff -- RPRX Sep 26, 2009
The Company's lead drug, Proellex, is being developed for the treatment of symptoms associated with uterine fibroids and endometriosis and as a pre-surgical treatment for anemia associated with excessive menstrual bleeding related to uterine fibroids. The Complaint charges the Company and certain of its executive officers with violations of the Securities Exchange Act of 1934, among other things, and further alleges that throughout the Class Period defendants knew or recklessly disregarded that... (Primezone Releases)
Repros Therapeutics finds funding Sep 9, 2009
After Repros (NASDAQ: RPRX) stopped the trials, it received a from shareholders alleging that the company misrepresented itself in news releases regarding the results of clinical trials for Proellex, a drug Repros had been testing for the treatment of chronic symptomatic uterine fibroids, anemia associated with this condition and endometriosis. Then late last week, Austin law firm LLP formally filed the securities class action lawsuit in the United States District Court for the Southern District... (Houston Business Journal, TX)
• Acid-reflux medication may lead to anemia Sep 3, 2009
Ultrasound is ordered to rule out uterine fibroids or to identify other causes of heavy menstrual bleeding. Unfortunately for your partner, he was late being diagnosed and his quality of life suffered dramatically. (Burley South Idaho Press, ID)
Repros in critical condition Aug 24, 2009
Repros voluntarily halted trials of the company s most promising drug, being tested to treat uterine fibroids, when patients reported severe side effects. According to the filing, the publicly traded firm had only $2. (Houston Business Journal, TX)
Non-invasive Brain Surgery Moves A Step Closer Aug 20, 2009
14, 2008) The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, noninvasive and effective, according to a recent study. According to the study, at 6 month follow-up, there. (Science Daily)
Obamacare and Hannan Ignite a Firestorm in Britain Aug 19, 2009
One friend, by way of comparison, was just diagnosed as having a large uterine fibroid tumor and was told to live with it. She is 80 and is in otherwise good health. (Human Events Online)
Interventional Radiology Treatment For Uterine Fibroids: Safe, Nonsurgical Option Aug 18, 2009
"UFE (also called uterine artery embolization or UAE) is a safe, effective and minimally invasive option for women to consider. This is especially significant news for the more than 300,000 women who have hysterectomies performed annually in the United States to treat symptomatic uterine fibroids. Many of these women can confidently choose UFE, and this could significantly decrease the hysterectomy rate in the United States," said Scott C. Goodwin, M.D., FSIR, an interventional radiologist who... (Science Daily)
Repros faces possible bankruptcy Aug 18, 2009
Proellex was being tested in the treatment of uterine fibroids and related conditions. Separately, shareholders have filed a class action lawsuit against the company and certain officers, alleging that the results of some Proellex trials were misrepresented. (Houston Business Journal, TX)
Uterine Fibroid Embolization Aug 13, 2009
Scott C. Goodwin, M.D., and James B. Spies, M.D., M.P.H.. Since this article has no abstract, we have provided an extract of the first 100 words of the and any section headings. (New England Journal of Medicine)
Repros facing class action lawsuit Aug 12, 2009
The complaint alleges that the company misrepresented itself in news releases regarding the results of clinical trials for Proellex, a drug the company had been testing for the treatment of chronic symptomatic uterine fibroids, anemia associated with this condition and endometriosis. On Aug. 3, Repros stopped trials of the drug citing patient safety after research found the occurrence of clinically significant increases in liver enzymes in nine patients given doses of 25 milligrams or more of... (Houston Business Journal, TX)
Civil Securities Claims Against Repros Therapeutics Inc. Being Investigated by The Rosen Law Firm, P.A. Aug 6, 2009
NEW YORK, Aug. 5, 2009 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against Repros Therapeutics, Inc. ("Repros") (Nasdaq: - ) pertaining to allegations that Repros misled investors about adverse events in the Company's clinical trials of Proellex which ultimately led the Company to suspend its clinical trials for Proellex, a drug it is developing for the treatment of chronic symptomatic uterine fibroids, anemia associated with this... (Primezone Releases)
Patient safety puts brakes on Repros trial Aug 4, 2009
Repros (NASDAQ: RPRX) has been working on Proellex for the treatment of chronic symptomatic uterine fibroids, anemia associated with this condition and endometriosis. Trials were expected to be completed in September but, instead, the company will work with the at that time to discuss future testing of the drug. (Houston Business Journal, TX)
A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders Jul 14, 2009
" Neurosurgeons currently treat patients with functional neurological disorders such as neuropathic pain or Parkinson's disease by inserting a tiny probe through the cranium and brain to reach and ablate damaged tissue. "The more traditional invasive treatment works to alleviate pain and other symptoms, however it exposes the patient to complications, including infections, bleeding and damage to surrounding brain tissue," Dr. Jeanmonod explained. "Also, only patients whose target tissue lies in... (Canada Newswire)
After a Hysterectomy Jul 14, 2009
Some of the most common causes are uterine fibroids, abnormal vaginal bleeding, cervical dysplasia, endometriosis, and uterine prolapse. Uterine Fibroids Fibroids tumors that grow in the wall of the uterus and are usually of a benign (non-cancerous) nature. (Suite101.com)
Non-invasive Brain Surgery: Successful Neurosurgery With Transcranial MR-guided High-Intensity Focused Ultrasound Jun 23, 2009
For quite some years, HIFU has been used for the treatment of uterine fibroids and tumors of the prostate gland ... 14, 2008) The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, noninvasive and effective, according to a recent study. (Science Daily)
NURSE’S NOTES - Women have surgery options May 20, 2009
Many women have to have gynecologic surgery in their lives, due to conditions such as uterine fibroids, endometriosis, uterine prolapse, excessive bleeding, or cervical or uterine cancer. In fact, hysterectomy procedures are the second most common surgical intervention for women in the United States. (Missoulian, MT)
InSightec Ltd. Announces US$15 Million Investment Round Mar 19, 2009
InSightec's President and CEO, Dr. Kobi Vortman said, "We are very proud in the ongoing trust we are receiving from our investors that share our vision that this technology is the enabler of the next generation operating room that will be a non-invasive and outpatient operating room." "The ExAblate(R) 2000 treatments of uterine fibroids continue to grow globally with excellent clinical results driving market adoption in more than 70 leading sites globally and over 4500 women treated worldwide.... (Canada Newswire)
* Gynecologist introduces new fibroids procedure Mar 4, 2009
Uterine fibroids are benign tumors that grow from the muscle layers of the uterus. BLEEDING. (Taipei Times, Taiwan -- World Business)
Gene Variant Raises Risk of Uterine Fibroids Feb 26, 2009
TUESDAY, Feb. 24 (HealthDay News) -- Researchers have found a genetic marker that may indicate if a woman has a greater chance of developing uterine fibroids, a new study says. Shorter, white women who test positive for the TC227 allele in their HMGA2 gene may be more likely to develop the muscular tumors in their uterus, according to a study of 248 pairs of sisters and their relatives. (MEDLINEplus)
CEO of Newnan biotech company was bitten by health care bug Feb 8, 2009
A: These are microspheres, called Embozene, that can be used, for example, to treat a uterine fibroid tumor. We re taking the microspheres, putting them through a catheter, taking them close to a tumor bed, and injecting a calibrated size into the appropriate vessel to shut off the blood supply to the tumor. (Atlanta Journal-Constitution -- Business)
